David Nierengarten
About David Nierengarten
David Nierengarten is a Managing Director at Wedbush Securities, specializing in biotechnology. He holds a Ph.D. in Biochemistry from the University of California, Berkeley, and has previously worked as an analyst at Research Corporation Technologies.
Work at Wedbush Securities
David Nierengarten has served as Managing Director at Wedbush Securities since 2010. He has worked in the San Francisco Bay Area for over a decade, focusing on the biotechnology sector. His role involves providing analysis and insights into various biotechnology companies, contributing to the firm's reputation in the investment community.
Education and Expertise
David Nierengarten holds a Ph.D. in Biochemistry from the University of California, Berkeley, where he studied from 1997 to 2003. He also earned a Bachelor of Science degree in Biochemistry from the University of Wisconsin-Madison, attending from 1993 to 1997. His educational background supports his specialization in biotechnology.
Background
David Nierengarten began his career as an Analyst at Research Corporation Technologies from 2003 to 2005 in the San Francisco Bay Area. This role provided him with foundational experience in analyzing biotechnology companies, which he later expanded upon in his current position at Wedbush Securities.
Achievements
In 2013, David Nierengarten achieved second place in Starmine's biotechnology analyst stock picking rankings. This recognition highlights his analytical skills and expertise in the biotechnology sector, showcasing his ability to identify promising investment opportunities.
Portfolio Management
As a lead analyst, David Nierengarten has managed a diverse portfolio of biotechnology companies, including AGTC, ANAB, ARGX, AVRO, BEAM, BLUE, and BPMC. His experience in evaluating these companies contributes to his effectiveness in providing investment recommendations and insights.